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INTRODUCTION 
Carcinoma ex pleomorphic adenoma (Ca ex PA, 
CXPA) is type of rare, aggressive, poorly understood 
malignancy usually occurring in the salivary glands 
and accounts for most cases of malignant mixed 
tumors reported in the literature.1-3 It is also known as 
carcinoma ex mixed tumor, carcinoma ex adenoma, 
and carcinoma ex benign pleomorphic adenoma.4 It 
was first described by Beahrs et al. in 1957 and accounts 
for 3. 6% of all salivary gland neoplasms and for 11.7% 
of salivary malignancies.5   
 
Various authors state that Carcinoma ex pleomorphic 
adenoma usually occurs in the 6th-8th decades of life.5,6  
As per the histological classification report of the 
World Health Organization (2005), the so called 
“malignant mixed tumors,” are divided into 3 different 
clinical and histologic entities: 1) carcinoma ex 
pleomorphic adenoma (carcinoma in pre-existing 
pleomorphic adenoma), 2) carcinosarcoma (true 
malignant mixed tumor), and 3) metastasizing 
pleomorphic adenoma. Literature search reveals that 
most malignant mixed tumors are carcinoma ex 
pleomorphic adenoma, whereas the latter 2 types are 
extremely unusual and rarely reported.7  
 
The gold standard for making an accurate diagnosis is 
pathological assessment and its treatment often 
involves an ablative surgical procedure, which may be 
followed by radiotherapy. It has been stated that 
patients with CXPA have a poor prognosis. This case 
report presents a case of Carcinoma ex pleomorphic 
adenoma affecting a 48 year old male patient.  
 
 
 
CASE REPORT 
A 48 year old male patient came to the department of 
Oral Medicine and Radiology with a chief complaint of 
a growth on the left side of the face since two years. 
The growth was initially small and gradually increased 
to the present size. There was history of associated 
pain since 1 month. Medical and past dental histories 
were non-relevant. General physical examination was 
non-contributory. Extra-oral examination revealed a 
growth of size 5x6 cms on the left side of the face 
extending anteroposteriorly 2 cms from corner of 
mouth to 5 cms posteriorly to the ear lobe. The post 
auricular area had a 7x8 mm growth [Figure 1(a) and 
(b)]. Skin over the growth was normal. There was no 
surface rise in temperature. It was slightly tender on 
palpation, soft-firm in consistency. It was non-
fluctuant, slightly compressible but non reducible.   
 
Diascopy test was negative. On intra-oral examination, 
no abnormality was detected. On the basis of history 
and clinical examination of the growth, a provisional 
diagnosis of a malignant tumor of the salivary gland 
was given.  A differential diagnosis of other malignant 
tumors was considered. The patient was sent for 
further investigations which included MRI (Figure 2) 
which confirmed the diagnosis of Carcinoma ex 
Pleomorphic Adenoma 
 
DISCUSSION 
Pleomorphic adenoma is the most common benign 
salivary gland neoplasm.8 The terms pleomorphic 
adenoma and mixed tumor both represent attempts to 
describe   this   tumor's    interesting    histopathologic   
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features. Malignant mixed tumors represent 
malignant counterparts to the benign mixed tumor or 
pleomorphic adenoma. These are a group of rare 
neoplasms which constitute 2% to 6% of all salivary 
gland tumors.8,9 
 
The most common of these is the carcinoma ex 
pleomorphic adenoma, which is characterized by 
malignant transformation of the epithelial component 
of a previously benign pleomorphic adenoma. The 
carcinosarcoma is a rare "mixed" tumor in which both 
carcinomatous and sarcomatous elements are present. 
The metastasizing mixed tumor has histopathologic 
features that are identical to the common pleomorphic 
adenoma. The lesion metastasizes despite its benign 
appearance. The metastatic tumor also has a benign 
microscopic appearance, usually similar to that of the 
primary lesion.8-10 
  
Carcinoma ex pleomorphic adenoma can be regarded 
as a malignant change in the previous benign tumor. 
The age of the patients is older than those affected by 
pleomorphic adenoma. Patients report of a growth 
present since many years and a recent history of pain 
can be reported.11 
 
It is most common in the parotid salivary glands. This 
is similar to the location of the tumor in the present 
case. Intra-orally, two-thirds of the cases have been 
documented on the palate. Ulceration may also be 
present. 
 
Histopathologically, areas of typical benign 
pleomorphic adenoma usually can be found and may 
constitute most or only a small portion of the lesion. 
Within the tumor are areas of malignant degeneration 
of the epithelial component characterized by cellular 
pleomorphism and abnormal mitotic activity.12 
 
The differential diagnosis includes other malignant 
tumors such as mucoepidermoid carcinoma, adenoid 
cystic carcinoma, acinic cell carcinoma.13  
 
Treatment plan includes complete parotidectomy with 
preservation of the facial nerve. Radiation therapy also 
has been proven useful. Well differentiated tumors 
have a favorable prognosis whereas poorly 
differentiated tumors have poor prognosis. 
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Figure 1(a) and (b). Growth on the left side of the face of the patient since two years 
  
Figure 2. MRI of the lesion confirming the diagnosis 
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